Attitudes and knowledge of hospital pharmacists to adverse drug reaction reporting

被引:91
作者
Green, CF
Mottram, DR
Rowe, PH
Pirmohamed, M
机构
[1] Liverpool John Moores Univ, Sch Pharm & Chem, Liverpool L3 3AF, Merseyside, England
[2] Univ Liverpool, Dept Pharmacol & Therapeut, Liverpool L69 3GE, Merseyside, England
关键词
adverse drug reaction; Committee on Safety of Medicines; hospital pharmacists; survey;
D O I
10.1046/j.1365-2125.2001.01306.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Aims To investigate the attitudes of UK hospital pharmacists towards, and their understanding, of adverse drug reaction (ADR) reporting. Methods A postal questionnaire survey of 600 randomly selected hospital pharmacists was conducted. Results The response rate was 53.7% (n=322). A total of 217 Yellow Cards had been submitted to the CSM/MCA by 78 (25.6%) of those responding. Half of those responding felt that ADR reporting should be compulsory and over three-quarters felt it was a professional obligation. However, almost half were unclear as to what should be reported, while the time available in clinical practice and time taken to complete forms were deemed to be major deterrents to reporting. Pharmacists were not dissuaded from reporting by the need to consult a medical colleague or by the absence of a fee. Education and training had a significant influence on pharmacists' participation in the Yellow Card Scheme. Conclusions Pharmacists have a reasonable knowledge and are supportive of the Yellow Card spontaneous ADR reporting scheme. However, education and training will be important in maintaining and increasing ADR reports from pharmacists.
引用
收藏
页码:81 / 86
页数:6
相关论文
共 18 条
[1]  
BATEMAN DN, 1992, BRIT J CLIN PHARMACO, V34, P421
[2]   ATTITUDINAL SURVEY OF ADVERSE DRUG REACTION REPORTING BY MEDICAL PRACTITIONERS IN THE UNITED-KINGDOM [J].
BELTON, KJ ;
LEWIS, SC ;
PAYNE, S ;
RAWLINS, MD ;
WOOD, SM .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1995, 39 (03) :223-226
[3]   Attitude survey of adverse drug-reaction reporting by health care professionals across the European Union [J].
Belton, KJ ;
Gram, LF ;
Royer, RJ ;
Feely, J ;
McGettigan, P ;
Velo, GP ;
Conforti, A ;
Leone, R ;
Stricker, BHC ;
Teixeira, F ;
Laporte, JP ;
Capella, D ;
Beermann, B ;
Lewis, SC ;
Payne, S ;
Rawlins, MD ;
Wood, SM .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1997, 52 (06) :423-427
[4]  
CAIRNS C, 1999, PHARM J, V262, P321
[5]  
Chaplin S., 1990, PRESCRIBER, V1, P36
[6]  
*CSM MCA, 1989, CURRENT PROBLEMS PHA, V26, P1
[7]  
DAVIS S, 1999, PHARM J, V262, P366
[8]   DRUG-RELATED HOSPITAL ADMISSIONS [J].
EINARSON, TR .
ANNALS OF PHARMACOTHERAPY, 1993, 27 (7-8) :832-840
[9]  
Eland IA, 1999, BRIT J CLIN PHARMACO, V48, P623
[10]  
Green C.F., 1999, INT JOUMAL PHARM PRA, V7, P247